Hyperfine, Inc. cash flow statement
In fiscal 2025, Hyperfine, Inc.'s operations generated −$27.9m of cash; it spent $1.2m on capital projects, leaving free cash flow of −$29.1m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −22 | −47 | −72 | −42 | −39 | −28 | −27 |
| Depreciation and amortisation | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 1 | 7 | 11 | 5 | 4 | 3 | 3 |
| Capital spending | 2 | 3 | 1 | 1 | 0 | 1 | 0 |
| Free cash flow | −23 | −50 | −73 | −43 | −39 | −29 | −28 |
| Free cash flow after stock pay | −24 | −57 | −84 | −47 | −44 | −32 | −30 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −9 | −8 | −9 | −8 | −6 | −5 | −9 | −7 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Free cash flow | −9 | −8 | −10 | −8 | −6 | −5 | −9 | −7 |
| Free cash flow after stock pay | −10 | −9 | −11 | −9 | −6 | −6 | −10 | −8 |
Compare with peers
- Sensus Healthcare, Inc. cash flow
- Spectral AI, Inc. cash flow
- Jin Medical International Ltd. cash flow
- Nephros Inc cash flow
- Vivos Therapeutics, Inc. cash flow
Head to head: HYPR vs SRTSHYPR vs MDAIHYPR vs ZJYL
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies